ArticleJPRAS open2025
Multiple bilateral breast hematomas as a complication of polyacrylamide hydrogel injection for breast augmentation: A case report.
Article in JPRAS open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We present the case of a female patient who underwent polyacrylamide hydrogel (PAAG) injection for breast augmentation 21 years ago and developed bilateral breast pain 2 years prior to evaluation. Preoperative magnetic resonance imaging (MRI) did not reveal any hematoma formation. However, intraoperative findings included multiple mural masses composed of dark red, fibrous clots, which were subsequently diagnosed as chronic organized hematomas. This case illustrates that organized hematoma may represent a distinct subtype of PAAG-related complications, likely resulting from long-term interactions between the physicochemical properties of PAAG and the local tissue microenvironment. It also highlights the diagnostic limitations of imaging in complex PAAG-associated pathology, suggesting that imaging should serve as an adjunct rather than a sole determinant in surgical decision-making. For patients with persistent pain or morphological changes of the breast, surgical exploration should be considered even in the absence of characteristic imaging findings. For asymptomatic patients, surgical intervention may also represent a beneficial option.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.